{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:47:47Z","timestamp":1767962867996,"version":"3.49.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,20]],"date-time":"2014-04-20T00:00:00Z","timestamp":1397952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11306-014-0659-5","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T10:25:29Z","timestamp":1397903129000},"page":"1210-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Biomarkers in renal cell carcinoma: a metabolomics approach"],"prefix":"10.1007","volume":"10","author":[{"given":"M\u00e1rcia S\u00e1","family":"Monteiro","sequence":"first","affiliation":[]},{"given":"M\u00e1rcia","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"given":"Paula Guedes","family":"de Pinho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,4,20]]},"reference":[{"issue":"6","key":"659_CR1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4172\/1948-5956.1000076","volume":"3","author":"T Abaffy","year":"2011","unstructured":"Abaffy, T., Moller, M., et al. (2011). A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control. Journal of Cancer Science and Therapy, 3(6), 140\u2013144.","journal-title":"Journal of Cancer Science and Therapy"},{"key":"659_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-013-0523-z","volume":"9","author":"T Abaffy","year":"2013","unstructured":"Abaffy, T., M\u00f6ller, M. G., et al. (2013). Comparative analysis of volatile metabolomics signals from melanoma and benign skin: A pilot study. Metabolomics, 9, 1\u201311.","journal-title":"Metabolomics"},{"issue":"4","key":"659_CR3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.eururo.2011.06.047","volume":"60","author":"F Algaba","year":"2011","unstructured":"Algaba, F., Akaza, H., et al. (2011). Current Pathology Keys of Renal Cell Carcinoma. European Urology, 60(4), 634\u2013643.","journal-title":"European Urology"},{"issue":"1","key":"659_CR4","first-page":"1","volume":"7","author":"MH Ather","year":"2010","unstructured":"Ather, M. H., Masood, N., et al. (2010). Current management of advanced and metastatic renal cell carcinoma. Urology Journal, 7(1), 1\u20139.","journal-title":"Urology Journal"},{"issue":"2","key":"659_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urolonc.2009.04.015","volume":"28","author":"M Basso","year":"2010","unstructured":"Basso, M., Cassano, A., et al. (2010). A survey of therapy for advanced renal cell carcinoma. Urologic Oncology, 28(2), 121\u2013133.","journal-title":"Urologic Oncology"},{"issue":"9","key":"659_CR6","doi-asserted-by":"crossref","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra, S., Aziat, F., et al. (2013). The human urine metabolome. PLoS ONE, 8(9), e73076.","journal-title":"PLoS ONE"},{"issue":"1","key":"659_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2010.10.006","volume":"21","author":"MC Brahimi-Horn","year":"2011","unstructured":"Brahimi-Horn, M. C., Bellot, G., et al. (2011). Hypoxia and energetic tumour metabolism. Current Opinion in Genetics & Development, 21(1), 67\u201372.","journal-title":"Current Opinion in Genetics & Development"},{"issue":"1\u20136","key":"659_CR8","first-page":"461","volume":"9","author":"P Cairns","year":"2010","unstructured":"Cairns, P. (2010). Renal cell carcinoma. Cancer Biomarkers, 9(1\u20136), 461\u2013473.","journal-title":"Cancer Biomarkers"},{"issue":"10","key":"659_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","volume":"2","author":"JR Cantor","year":"2012","unstructured":"Cantor, J. R., & Sabatini, D. M. (2012). Cancer cell metabolism: one hallmark, many faces. Cancer Discovery, 2(10), 881\u2013898.","journal-title":"Cancer Discovery"},{"key":"659_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2012\/161837","volume":"2012","author":"S Cardaci","year":"2012","unstructured":"Cardaci, S., & Ciriolo, M. R. (2012). TCA cycle defects and cancer: When metabolism tunes redox State. International Journal of Cell Biology, 2012, 9.","journal-title":"International Journal of Cell Biology"},{"issue":"1","key":"659_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1582-4934.2009.00939.x","volume":"15","author":"G Catchpole","year":"2011","unstructured":"Catchpole, G., Platzer, A., et al. (2011). Metabolic profiling reveals key metabolic features of renal cell carcinoma. Journal of Cellular and Molecular Medicine, 15(1), 109\u2013118.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"659_CR12","first-page":"16","volume":"2013","author":"C Cerella","year":"2013","unstructured":"Cerella, C., Radogna, F., et al. (2013). Natural compounds as regulators of the cancer cell metabolism. International Journal of Cell Biology, 2013, 16.","journal-title":"International Journal of Cell Biology"},{"key":"659_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-375672-5.10003-9","volume-title":"Biomarkers in kidney disease","author":"U Christians","year":"2011","unstructured":"Christians, U., Albuisson, J., et al. (2011). Chapter 3\u2014the role of metabolomics in the study of kidney diseases and in the development of diagnostic tools. In L. E. Charles & C. L. Edelstein (Eds.), Biomarkers in kidney disease (pp. 39\u2013100). San Diego: Academic Press."},{"issue":"23","key":"659_CR14","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","volume":"353","author":"HT Cohen","year":"2005","unstructured":"Cohen, H. T., & McGovern, F. J. (2005). Renal-cell carcinoma. The New England Journal of Medicine, 353(23), 2477\u20132490.","journal-title":"The New England Journal of Medicine"},{"issue":"19","key":"659_CR15","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.4161\/cc.9.19.13302","volume":"9","author":"CV Dang","year":"2010","unstructured":"Dang, C. V. (2010). Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle, 9(19), 3884\u20133886.","journal-title":"Cell Cycle"},{"issue":"9","key":"659_CR16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","volume":"26","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. (2012). Links between metabolism and cancer. Genes & Development, 26(9), 877\u2013890.","journal-title":"Genes & Development"},{"issue":"5","key":"659_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jso.21831","volume":"103","author":"VW Davis","year":"2011","unstructured":"Davis, V. W., Bathe, O. F., et al. (2011). Metabolomics and surgical oncology: Potential role for small molecule biomarkers. Journal of Surgical Oncology, 103(5), 451\u2013459.","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"659_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J., Lum, J. J., et al. (2008a). The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism, 7(1), 11\u201320.","journal-title":"Cell Metabolism"},{"issue":"1","key":"659_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","volume":"18","author":"RJ Deberardinis","year":"2008","unstructured":"Deberardinis, R. J., Sayed, N., et al. (2008b). Brick by brick: Metabolism and tumor cell growth. Current Opinion in Genetics & Development, 18(1), 54\u201361.","journal-title":"Current Opinion in Genetics & Development"},{"issue":"22","key":"659_CR20","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1158\/0008-5472.CAN-06-0755","volume":"66","author":"C Denkert","year":"2006","unstructured":"Denkert, C., Budczies, J., et al. (2006). Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Research, 66(22), 10795\u201310804.","journal-title":"Cancer Research"},{"issue":"10 Suppl","key":"659_CR21","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.24233","volume":"115","author":"A Napoli Di","year":"2009","unstructured":"Di Napoli, A., & Signoretti, S. (2009). Tissue biomarkers in renal cell carcinoma: Issues and solutions. Cancer, 115(10 Suppl), 2290\u20132297.","journal-title":"Cancer"},{"issue":"6","key":"659_CR22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.coph.2012.08.002","volume":"12","author":"HA Drabkin","year":"2012","unstructured":"Drabkin, H. A., & Gemmill, R. M. (2012). Cholesterol and the development of clear-cell renal carcinoma. Current Opinion in Pharmacology, 12(6), 742\u2013750.","journal-title":"Current Opinion in Pharmacology"},{"issue":"1\u20132","key":"659_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","volume":"48","author":"O Fiehn","year":"2002","unstructured":"Fiehn, O. (2002). Metabolomics\u2013the link between genotypes and phenotypes. Plant Molecular Biology, 48(1\u20132), 155\u2013171.","journal-title":"Plant Molecular Biology"},{"issue":"14","key":"659_CR24","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1158\/0008-5472.CAN-11-3105","volume":"72","author":"S Ganti","year":"2012","unstructured":"Ganti, S., Taylor, S. L., et al. (2012a). Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Research, 72(14), 3471\u20133479.","journal-title":"Cancer Research"},{"issue":"12","key":"659_CR25","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/ijc.26274","volume":"130","author":"S Ganti","year":"2012","unstructured":"Ganti, S., Taylor, S. L., et al. (2012b). Urinary acylcarnitines are altered in human kidney cancer. International Journal of Cancer, 130(12), 2791\u20132800.","journal-title":"International Journal of Cancer"},{"issue":"5","key":"659_CR26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.urolonc.2011.05.013","volume":"29","author":"S Ganti","year":"2011","unstructured":"Ganti, S., & Weiss, R. H. (2011). Urine metabolomics for kidney cancer detection and biomarker discovery. Urologic Oncology, 29(5), 551\u2013557.","journal-title":"Urologic Oncology"},{"issue":"2","key":"659_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.aca.2008.06.051","volume":"624","author":"H Gao","year":"2008","unstructured":"Gao, H., Dong, B., et al. (2008). Metabonomic profiling of renal cell carcinoma: High-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. Analytica Chimica Acta, 624(2), 269\u2013277.","journal-title":"Analytica Chimica Acta"},{"issue":"5","key":"659_CR28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00432-011-1134-6","volume":"138","author":"H Gao","year":"2012","unstructured":"Gao, H., Dong, B., et al. (2012). Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases. Journal of Cancer Research and Clinical Oncology, 138(5), 753\u2013761.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"659_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrc2255","volume":"8","author":"RA Gatenby","year":"2008","unstructured":"Gatenby, R. A., & Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nature Reviews Cancer, 8(1), 56\u201361.","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"659_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-005-1102-8","volume":"1","author":"JB German","year":"2005","unstructured":"German, J. B., Hammock, B. D., et al. (2005). Metabolomics: building on a century of biochemistry to guide human health. Metabolomics, 1(1), 3\u20139.","journal-title":"Metabolomics"},{"issue":"3","key":"659_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10863-007-9085-y","volume":"39","author":"R Gillies","year":"2007","unstructured":"Gillies, R., & Gatenby, R. (2007a). Adaptive landscapes and emergent phenotypes: Why do cancers have high glycolysis? Journal of Bioenergetics and Biomembranes, 39(3), 251\u2013257.","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"2","key":"659_CR32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10555-007-9065-z","volume":"26","author":"R Gillies","year":"2007","unstructured":"Gillies, R., & Gatenby, R. (2007b). Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer and Metastasis Reviews, 26(2), 311\u2013317.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"5","key":"659_CR33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674.","journal-title":"Cell"},{"issue":"5","key":"659_CR34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P. P., & Sabatini, D. M. (2008). Cancer cell metabolism: Warburg and beyond. Cell, 134(5), 703\u2013707.","journal-title":"Cell"},{"issue":"7","key":"659_CR35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1541-7786.MCR-12-0117","volume":"10","author":"E Jonasch","year":"2012","unstructured":"Jonasch, E., Futreal, P. A., et al. (2012). State of the science: An update on renal cell carcinoma. Molecular Cancer Research, 10(7), 859\u2013880.","journal-title":"Molecular Cancer Research"},{"issue":"5","key":"659_CR36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","volume":"23","author":"RG Jones","year":"2009","unstructured":"Jones, R. G., & Thompson, C. B. (2009). Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes & Development, 23(5), 537\u2013548.","journal-title":"Genes & Development"},{"issue":"18 Pt 2","key":"659_CR37","doi-asserted-by":"crossref","first-page":"6290S","DOI":"10.1158\/1078-0432.CCR-sup-040025","volume":"10","author":"WG Kaelin Jr","year":"2004","unstructured":"Kaelin, W. G, Jr. (2004). The von Hippel\u2013Lindau tumor suppressor gene and kidney cancer. Clinical Cancer Research, 10(18 Pt 2), 6290S\u20136295S.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"659_CR38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1074\/mcp.M800165-MCP200","volume":"8","author":"K Kim","year":"2009","unstructured":"Kim, K., Aronov, P., et al. (2009). Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Molecular and cellular proteomics, 8(3), 558\u2013570.","journal-title":"Molecular and cellular proteomics"},{"issue":"7","key":"659_CR39","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1021\/pr100236r","volume":"9","author":"DS Kim","year":"2010","unstructured":"Kim, D. S., Choi, Y. P., et al. (2010). Panel of candidate biomarkers for renal cell carcinoma. Journal of Proteome Research, 9(7), 3710\u20133719.","journal-title":"Journal of Proteome Research"},{"issue":"5","key":"659_CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/omi.2010.0094","volume":"15","author":"K Kim","year":"2011","unstructured":"Kim, K., Taylor, S. L., et al. (2011). Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS: A Journal of Integrative Biology, 15(5), 293\u2013303.","journal-title":"OMICS: A Journal of Integrative Biology"},{"issue":"2","key":"659_CR41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ab.2007.01.028","volume":"363","author":"T Kind","year":"2007","unstructured":"Kind, T., Tolstikov, V., et al. (2007). A comprehensive urinary metabolomic approach for identifying kidney cancerr. Analytical Biochemistry, 363(2), 185\u2013195.","journal-title":"Analytical Biochemistry"},{"issue":"10","key":"659_CR42","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","volume":"15","author":"DJ Kominsky","year":"2009","unstructured":"Kominsky, D. J., Klawitter, J., et al. (2009). Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Clinical Cancer Research, 15(10), 3442\u20133450.","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"659_CR43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G., & Pouyssegur, J. (2008). Tumor cell metabolism: Cancer\u2019s Achilles\u2019 Heel. Cancer cell, 13(6), 472\u2013482.","journal-title":"Cancer cell"},{"issue":"3","key":"659_CR44","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/pr101161u","volume":"10","author":"L Lin","year":"2011","unstructured":"Lin, L., Huang, Z., et al. (2011). LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. Journal of Proteome Research, 10(3), 1396\u20131405.","journal-title":"Journal of Proteome Research"},{"issue":"11","key":"659_CR45","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1039\/c0an00265h","volume":"135","author":"L Lin","year":"2010","unstructured":"Lin, L., Yu, Q., et al. (2010). Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst, 135(11), 2970\u20132978.","journal-title":"Analyst"},{"issue":"5","key":"659_CR46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan, W. M., Srinivasan, R., et al. (2010). The genetic basis of kidney cancer: A metabolic disease. Nat Rev Urol, 7(5), 277\u2013285.","journal-title":"Nat Rev Urol"},{"key":"659_CR47","volume-title":"Guidelines on renal cell carcinoma","author":"B Ljungberg","year":"2010","unstructured":"Ljungberg, B., Cowan, N., et al. (2010a). Guidelines on renal cell carcinoma. Arnhem: European Association of Urology."},{"issue":"3","key":"659_CR48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.eururo.2010.06.032","volume":"58","author":"B Ljungberg","year":"2010","unstructured":"Ljungberg, B., Cowan, N. C., et al. (2010b). EAU guidelines on renal cell carcinoma: The 2010 update. European Urology, 58(3), 398\u2013406.","journal-title":"European Urology"},{"issue":"1","key":"659_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2012.06.006","volume":"23","author":"H Moch","year":"2013","unstructured":"Moch, H. (2013). An overview of renal cell cancer: Pathology and genetics. Seminars in Cancer Biology, 23(1), 3\u20139.","journal-title":"Seminars in Cancer Biology"},{"issue":"2","key":"659_CR50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/092986713804806621","volume":"20","author":"MS Monteiro","year":"2013","unstructured":"Monteiro, M. S., Carvalho, M., et al. (2013). Metabolomics analysis for biomarker discovery: advances and challenges. Current Medicinal Chemistry, 20(2), 257\u2013271.","journal-title":"Current Medicinal Chemistry"},{"issue":"7381","key":"659_CR51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2012","unstructured":"Mullen, A. R., Wheaton, W. W., et al. (2012). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature, 481(7381), 385\u2013388.","journal-title":"Nature"},{"issue":"7216","key":"659_CR52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","volume":"455","author":"JK Nicholson","year":"2008","unstructured":"Nicholson, J. K., & Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455(7216), 1054\u20131056.","journal-title":"Nature"},{"issue":"5","key":"659_CR53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ijc.20651","volume":"113","author":"K Odunsi","year":"2005","unstructured":"Odunsi, K., Wollman, R. M., et al. (2005). Detection of epithelial ovarian cancer using 1H NMR-based metabonomics. International Journal of Cancer, 113(5), 782\u2013788.","journal-title":"International Journal of Cancer"},{"issue":"4","key":"659_CR54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2011.06.048","volume":"60","author":"E Oosterwijk","year":"2011","unstructured":"Oosterwijk, E., Rathmell, W. K., et al. (2011). Basic research in kidney cancer. European Urology, 60(4), 622\u2013633.","journal-title":"European Urology"},{"key":"659_CR55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-5-64","volume":"5","author":"B Perroud","year":"2006","unstructured":"Perroud, B., Lee, J., et al. (2006). Pathway analysis of kidney cancer using proteomics and metabolic profiling. Molecular Cancer, 5, 64.","journal-title":"Molecular Cancer"},{"issue":"4","key":"659_CR56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5489\/cuaj.10196","volume":"5","author":"JH Pinthus","year":"2011","unstructured":"Pinthus, J. H., Whelan, K. F., et al. (2011). Metabolic features of clear-cell renal cell carcinoma: Mechanisms and clinical implications. Canadian Urological Association Journal, 5(4), 274\u2013282.","journal-title":"Canadian Urological Association Journal"},{"issue":"1","key":"659_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11306-010-0234-7","volume":"7","author":"L Rasmussen","year":"2011","unstructured":"Rasmussen, L., Savorani, F., et al. (2011). Standardization of factors that influence human urine metabolomics. Metabolomics, 7(1), 71\u201383.","journal-title":"Metabolomics"},{"issue":"6","key":"659_CR58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2012.11.010","volume":"16","author":"S Ros","year":"2012","unstructured":"Ros, S., & Schulze, A. (2012). Linking glycogen and senescence in cancer cells. Cell Metabolism, 16(6), 687\u2013688.","journal-title":"Cell Metabolism"},{"issue":"4","key":"659_CR59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11306-007-0091-1","volume":"3","author":"E Saude","year":"2007","unstructured":"Saude, E., Adamko, D., et al. (2007). Variation of metabolites in normal human urine. Metabolomics, 3(4), 439\u2013451.","journal-title":"Metabolomics"},{"issue":"1","key":"659_CR60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11306-006-0042-2","volume":"3","author":"E Saude","year":"2007","unstructured":"Saude, E., & Sykes, B. (2007). Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics, 3(1), 19\u201327.","journal-title":"Metabolomics"},{"issue":"24","key":"659_CR61","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1002\/pmic.200700415","volume":"7","author":"B Seliger","year":"2007","unstructured":"Seliger, B., Dressler, S. P., et al. (2007). Candidate biomarkers in renal cell carcinoma. Proteomics, 7(24), 4601\u20134612.","journal-title":"Proteomics"},{"issue":"6","key":"659_CR62","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/pmic.200700288","volume":"9","author":"B Seliger","year":"2009","unstructured":"Seliger, B., Dressler, S. P., et al. (2009). Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics, 9(6), 1567\u20131581.","journal-title":"Proteomics"},{"issue":"10","key":"659_CR63","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/pmic.200401264","volume":"5","author":"B Seliger","year":"2005","unstructured":"Seliger, B., Lichtenfels, R., et al. (2005). Identification of fatty acid binding proteins as markers associated with the initiation and\/or progression of renal cell carcinoma. Proteomics, 5(10), 2631\u20132640.","journal-title":"Proteomics"},{"issue":"4","key":"659_CR64","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","volume":"8","author":"GL Semenza","year":"2002","unstructured":"Semenza, G. L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends in Molecular Medicine, 8(4), S62\u2013S67.","journal-title":"Trends in Molecular Medicine"},{"issue":"6","key":"659_CR65","first-page":"572","volume":"9","author":"NJ Serkova","year":"2007","unstructured":"Serkova, N. J., Spratlin, J. L., et al. (2007). NMR-based metabolomics: translational application and treatment of cancer. Current Opinion in Molecular Therapeutics, 9(6), 572\u2013585. [ABSTRACT].","journal-title":"Current Opinion in Molecular Therapeutics"},{"issue":"6","key":"659_CR66","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ceb.2006.10.005","volume":"18","author":"RJ Shaw","year":"2006","unstructured":"Shaw, R. J. (2006). Glucose metabolism and cancer. Current Opinion in Cell Biology, 18(6), 598\u2013608.","journal-title":"Current Opinion in Cell Biology"},{"issue":"2","key":"659_CR67","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin, J. L., Serkova, N. J., et al. (2009). Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research, 15(2), 431\u2013440.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"659_CR68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2012.09.054","volume":"63","author":"S Sudarshan","year":"2013","unstructured":"Sudarshan, S., Karam, J. A., et al. (2013). Metabolism of kidney cancer: From the lab to clinical practice. European Urology, 63(2), 244\u2013251.","journal-title":"European Urology"},{"issue":"2","key":"659_CR69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urology.2006.09.060","volume":"69","author":"T Teratani","year":"2007","unstructured":"Teratani, T., Domoto, T., et al. (2007). Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma. Urology, 69(2), 236\u2013240.","journal-title":"Urology"},{"key":"659_CR70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-12-375672-5.10008-8","volume-title":"Biomarkers in kidney disease","author":"NS Vasudev","year":"2011","unstructured":"Vasudev, N. S., & Banks, R. E. (2011). Chapter 8\u2014biomarkers of renal cancer. In L. E. Charles & L. C. Edelstein (Eds.), Biomarkers in kidney disease (pp. 313\u2013350). San Diego: Academic Press."},{"key":"659_CR71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.113622","volume":"12","author":"KA Vermeersch","year":"2013","unstructured":"Vermeersch, K. A., & Styczynski, M. P. (2013). Applications of metabolomics in cancer research. Journal of Carcinogenesis, 12, 9.","journal-title":"Journal of Carcinogenesis"},{"issue":"3","key":"659_CR72","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/84.3.531","volume":"84","author":"MC Walsh","year":"2006","unstructured":"Walsh, M. C., Brennan, L., et al. (2006). Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. The American Journal of Clinical Nutrition, 84(3), 531\u2013539.","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"3191","key":"659_CR73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. (1956). On the origin of cancer cells. Science, 123(3191), 309\u2013314.","journal-title":"Science"},{"issue":"1","key":"659_CR74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneph.2011.152","volume":"8","author":"RH Weiss","year":"2012","unstructured":"Weiss, R. H., & Kim, K. (2012). Metabolomics in the study of kidney diseases. Nature Reviews. Nephrology, 8(1), 22\u201333.","journal-title":"Nature Reviews. Nephrology"},{"issue":"1\u20132","key":"659_CR75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchromb.2004.09.032","volume":"813","author":"J Yang","year":"2004","unstructured":"Yang, J., Xu, G., et al. (2004). Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. Journal of Chromatography B, 813(1\u20132), 59\u201365.","journal-title":"Journal of Chromatography B"},{"issue":"4","key":"659_CR76","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","volume":"75","author":"A Zhang","year":"2012","unstructured":"Zhang, A., Sun, H., et al. (2012a). Recent and potential developments of biofluid analyses in metabolomics. Journal of Proteomics, 75(4), 1079\u20131088.","journal-title":"Journal of Proteomics"},{"key":"659_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2012.08.016","volume":"414C","author":"A Zhang","year":"2012","unstructured":"Zhang, A., Sun, H., et al. (2012b). Urine metabolomics. Clinica Chimica Acta, 414C, 65\u201369.","journal-title":"Clinica Chimica Acta"},{"issue":"8","key":"659_CR78","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1021\/pr100226m","volume":"9","author":"AN Zira","year":"2010","unstructured":"Zira, A. N., Theocharis, S. E., et al. (2010). 1H NMR Metabonomic Analysis in Renal Cell Carcinoma: A Possible Diagnostic Tool. Journal of Proteome Research, 9(8), 4038\u20134044.","journal-title":"Journal of Proteome Research"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-014-0659-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11306-014-0659-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-014-0659-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-014-0659-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T14:15:25Z","timestamp":1565360125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11306-014-0659-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,20]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1007\/s11306-014-0659-5","relation":{},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"value":"1573-3882","type":"print"},{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,20]]}}}